Latest Regulatory Risks News

American Tungsten & Antimony Ltd (ASX, AT4) has initiated drilling at its Utah antimony project and expanded its Nevada tungsten portfolio, while preparing a spin-out IPO of Australian assets to sharpen its US focus.

Conrad Asia Energy and Empyrean Energy have reached a binding settlement over historical cash call arrears in the Duyung Production Sharing Contract, involving asset transfers and payments that realign project interests and support the Mako gas field’s development timeline.

Lloyds Banking Group reported a robust 2025 performance with a 12% rise in statutory profit before tax and upgraded its 2026 guidance, underpinned by strong loan growth and digital innovation. The Group also announced significant shareholder returns totalling £3.9 billion, including dividends and a share buyback programme.

Bioxyne Limited has delivered a record-breaking second quarter in FY2026, posting $17.2 million in revenue and expanding its footprint into key international markets. The company’s growth is underpinned by new contracts, innovative psychedelics products, and strategic government funding.

Patrys Limited has acquired Reliis, gaining a promising injectable formulation of quetiapine aimed at treating delirium with a rapid FDA approval pathway. This move positions Patrys at the forefront of addressing a significant unmet medical need in critical care.

Highfield Resources has secured a A$10 million investment from existing strategic shareholders, extending its financial runway through early 2027 while awaiting a critical Spanish Supreme Court ruling on its Goyo mining permit appeal.

AUB Group Limited has announced the acquisition of a 95.9% stake in UK-based PIHL Holdings Limited (Prestige) for AUD 432 million, significantly expanding its UK retail insurance broking footprint. To fund this strategic move, AUB is launching a fully underwritten AUD 400 million institutional placement alongside a share purchase plan.

Legacy Minerals has locked in $4 million through an underwriting agreement to ensure full exercise of its listed options, bolstering its cash reserves to $10 million for advancing exploration at Mt Carrington.

VHM Limited has made significant strides in developing its Goschen Rare Earths and Mineral Sands Project, securing substantial funding and critical regulatory approvals while expanding its resource base.

Mayfield Childcare Limited’s board has issued a Target’s Statement recommending shareholders reject Embark Early Education’s unsolicited takeover offer, citing undervaluation and significant risks. The offer, which includes a scrip or cash option, is seen as opportunistically timed amid Mayfield’s operational turnaround.

Atomo Diagnostics has locked in exclusive global rights to a novel liver function test that rapidly detects liver injury, expanding its footprint in point-of-care diagnostics. The test, delivered on Atomo’s Pascal platform, targets drug-induced liver injury and chronic liver conditions with significant commercial potential.

Auris Minerals Limited has been queried by the ASX following a sharp rise in its share price and trading volume, with the company denying any undisclosed information behind the surge.